Table 1.

Clinical characteristics.

Number of patients, n	23
Age, yrs	71 ± 13 (25–90)
Sex (Male/Female)	14/9
Comorbidities, n (%)
Coronary Artery Disease	11 (48)
History of MI	2 (9)
Hypertension	17 (74)
Hyperlipidemia	12 (52)
Diabetes Mellitus	0
Atrial fibrillation	11 (48)
Heart failure	8 (35)
Echocardiography parameters
LVEF, %	57 ± 14
LVDD, cm	5.2 ± 0.9
LVSD, cm	4.0 ± 1.2
IV septum thickness, cm	1.3 ± 0.4
LV posterior wall thickness, cm	1.1 ± 0.4
Medications, n (%)
Beta blockers	13 (57)
ACE/ARB inhibitors	5 (22)
Calcium blockers	1 (4)
Metformin	0
Insulin	3 (13)
Statins	5 (22)
Cardiac surgeries, n (%)
CABG alone	2 (9)
Valve repair alone	10 (44)
CABG and valve repair	6 (26)

Data shown as number of patients (n) and percent of total number in parenthesis (%). Age, left ventricular ejection fraction (LVEF), left ventricular diastolic dimension (LVDD), left ventricular systolic dimension (LVSD), intraventricular (IV) septum thickness, left ventricular (LV) posterior wall thickness are presented as the mean ± standard deviation (SD). MI, myocardial infarction; ACE I, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor antagonists; CABG, coronary artery bypass grafting.